Trending July 27, 2026 2 min read Save Kansas City man potentially cured of HIV SPONSORED CONTENT June 26, 2026 1 min read Save FDA approves Skyrizi for pediatric use in psoriatic disease The FDA approved risankizumab-rzaa for children aged at least 6 years with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy or active psoriatic arthritis, AbbVie announced in a press release
How Personalized Genetics Influence Your GLP-1 Response Your genetic makeup influences how effectively semaglutide and tirzepatide work in your body
doi:10.1016/S0140-6736(13)62062-0
Note any history of diabetes, thyroid issues, or gastrointestinal concerns
The delayed gastric emptying effect often attenuates over time with long-acting GLP-1 agonists through tachyphylaxis, though the weight loss and glycemic benefits typically persist
The blend is typically sold as 10mg tesamorelin + 3mg ipamorelin in a single vial for convenience